Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review tandfonline.com/doi/full/10.10…

⁦BSG bsg.org.uk/web-education-…

Great meeting #ILC2022 and thanks for the opportunity to present our work EASLnews EASL Education. We need more research in ChILI to develop evidence based guidelines

Confirmation bias is twisting the facts to fit your beliefs. Critical thinking is bending your beliefs to fit the facts. Seeking the truth is not about validating the story in your head. It's about rigorously vetting and accepting the story that matches the reality in the world.

COVID Vaccine Hepatotoxicity ✅International series of 87 cases of hepatitis in Dec HEPATOLOGY ✅53% steroid treated; only 1 death ✅ mRNA COVID vaccines are indeed safe in light of frequency of use vs AE. #LiverTwitter

You can’t refute data with opinions. The best way to challenge evidence is with better evidence. Confirmation bias is dismissing inconvenient facts. Critical thinking is questioning your beliefs. The goal of learning is to pursue what's true, not defend your views.

Important results highlighting the role of pharmacogenomics in Co-amoxiclav-induced liver injury

📑 Hepatotoxicity of Immune Checkpoint Inhibitors: What is currently known 💡Highest incidence with triple 💊 💡Incidence similar between dual regimens 💡Risk similar between PD-1 & CTLA-4 inhibitor monotherapy #LiverTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…

Holding opposing ideas and the half-life of truth sciencedirect.com/science/articl… Vincent Di Martino Journal of Hepatology

For anyone interested in checkpoint inhibitor-induced liver injury (ChILI) please get in touch to join the largest retrospective cohort study in ChILI (uknotch.com/chiliproject)

If you use Immunotherapy or treat the toxicities please fill out our National Institute for Health and Care Research Immuno-Oncology Clinical Network survey on IO-induced hepatitis care. Help us learn and improve how to manage patients with this common complication! forms.office.com/Pages/Response… Brent O'Carrigan Anna Olsson-Brown #IOCN

It has been a great few days in Larissa discussing difficult AIH and PBC and making new friends! Thanks for organising and see you all soon

Excited to share our results on incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury ⁦JHEP Reports⁩ ⁦Brent O'Carrigan⁩ ⁦Immuno-Oncology Clinical Network⁩ #LiverTwitter jhep-reports.eu/article/S2589-…

🟪NEW Article in press❕ Incidence, risk factors and outcomes of checkpoint inhibitor-induced #liverinjury: a 10-year real-world retrospective cohort study 🔓#OpenAccess at👉bit.ly/43OyRnC Edmond Atallah #LiverTwitter

We have an exciting Clinical Fellow vacancy - closing date 30th May 2024! jobs.nottingham.ac.uk/vacancy.aspx?r…